Home » Health & Medicine, News & Current Affairs, Pharmaceuticals & Biotech, World » Global Intra-Uterine Contraceptive Devices Market will be worth USD 4.4 billion by 2022 – New market report by Data Bridge Market Research
“Global Intra-Uterine Contraceptive Devices Market is expected to grow at 3.5% in the forecast period 2016 to 2022”
Global Intra-Uterine Contraceptive Devices, By Product Type (Hormonal IUCD, Copper IUCD), By End-User (Hospitals, Gynaecology Clinics, Community Healthcare), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Trends and Forecast to 2022

Global Intra-Uterine Contraceptive Devices, By Product Type (Hormonal IUCD, Copper IUCD), By End-User (Hospitals, Gynecology Clinics, Community Healthcare), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Trends and Forecast to 2022

Global Intra-Uterine Contraceptive Devices Market is expected to reach USD 4.4 billion by 2022, from USD 3.5 billion in 2015 growing at a CAGR of 3.5% during the forecast period of 2016 to 2022.

Intrauterine contraceptive devices are most commonly known as IUDs/IUCDs. These devices are inserted into the uterus by doctors and other healthcare professionals to prevent contraception, by either immobilizing the sperms on their way to the fallopian tubes or by changing the uterine lining, so that the fertilized egg cannot be implanted in it.

For Sample Report: http://databridgemarketresearch.com/reports/global-intra-uterine-contraceptive-devices-market/

The Global Intra-Uterine Contraceptive Devices Market is segmented based on product type, end-user and geography.

Based on product type the market is segmented into copper IUCD and hormonal IUCD.

On the basis of end-user the market is segmented into Hospitals, Gynaecology Clinics, Community Healthcare.

To read more about the scope and findings of this report visit: http://databridgemarketresearch.com/intra-uterine-contraceptive-devices-market-poised-grow-3-5/

Based on geography the market is segmented into 5 geographical regions which are North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market shares countries like U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa.

The Global Intra-Uterine Contraceptive Devices Market is highly competitive and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report also includes company share analysis for the major companies operating in this market by major regions global, Europe, North America, Asia Pacific and Rest of the World.

Major players operating in the global intra-uterine contraceptive market are Bayer HealthCare AG (A subsidiary of Bayer AG), DKT International, Egemen International, Melbea AG, Teva Pharmaceuticals Industries Ltd., Actavis Plc., Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA and, SMB Corporation and Meril Life Sciences Pvt. Ltd. among others.

To Browse Full Report and Pricing: http://databridgemarketresearch.com/reports/global-intra-uterine-contraceptive-devices-market/

 

Table of Content:

1. INTRODUCTION

    1.1. OVERVIEW OF THE INTRA-UTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET

    1.2. MARKET SEGMENTATION & COVERAGE

          1.2.1. Currency and pricing 

          1.2.2. Limitation

          1.2.3. Stakeholders

2. RESEARCH METHODOLOGY

    2.1. Key takeaways

    2.2. ARRIVING AT THE INTRA-UTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET SIZE

          2.2.1. Market Crackdown Approach 

          2.2.2. Company Revenue and Market Share Analysis

          2.2.3. Data Triangulation

          2.2.4. KEY DATA POINTS FROM PRIMARY SOURCEs

          2.2.5. KEY DATA POINTS FROM SECONDARY SOURCEs

          2.2.6. Porter’s five forces matrix

    2.4. GLOBAL INTRA-UTERINE CONTRACEPTIVE DEVICES market: RESEARCH SNAPSHOT

    2.5. ASSUMPTIONS

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

    4.1. OVERVIEW

    4.2. Global INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET: KEY PRIMARY INSIGHTS

    4.3. MARKET OVERVIEW

          4.3.1. DRIVERS

                   4.3.1.1. INCREASING RATE OF UNPLANNED PREGNANCIES

                   4.3.1.2. POPULATION CONTROL POLICIES

                   4.3.1.3. RISING INITIATIVES BY THE PRIVATE FIRMS AND NGO’S

                   4.3.1.4. FAVOURABLE REIMBURSEMENTS

                   4.3.1.5. GROWING AWARENESS OF CONTRACEPTIVE USAGE

                   4.3.1.6. GROWING FUNDS AND GRANTS FOR IUCD DEVICES

                   4.3.1.7. TECHNOLOGICAL ADVANCEMENTS

          4.3.2. RESTRAINTS

                   4.3.2.1. HIGH COST OF TREATMENT

                   4.3.2.2. THREAT OF CAUSING PELVIC INFLAMMATORY DISEASES PID)

                   4.3.2.3. THREAT OF ECTOPIC PREGNANCY

          4.3.3. OPPURTUNITIES

                   4.3.3.1. Increasing Demand For Generic Injectables

          4.3.4. THREATS

    4.4. Key Market Trends and Upcoming Technologies

5. EXECUTIVE SUMMARY

6. IUCD MARKET, BY PRODUCT TYPE

    6.1. OVERVIEW

    6.2. HORMONAL IUCD (2014 – 2022)

          6.2.1. MARKET VALUE (USD MILLION)

          6.2.2. MARKET VOLUME (UNITS SOLD)

    6.3. COPPER IUCD (2014 – 2022)

          6.3.1. MARKET VALUE (USD MILLION)

          6.3.2. MARKET VOLUME (UNITS SOLD)

7. IUCD MARKET, BY END USER

    7.1. OVERVIEW

    7.2. Hospitals

    7.3. GYNECOLOGY CLINICS

    7.4. COMMUNITY HEALTHCARE

8. IUCD MARKET, BY GEOGRAPHY

    8.1.       COUNTRYWISE INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS                     REPRESENTED IN THIS CHAPTER BY COUNTRY)

                8.1.1. NORTH AMERICA

                         8.1.1.1. U.S.

                         8.1.1.2. CANADA

                         8.1.1.3. MEXICO

                8.1.2. EUROPE

                         8.1.2.1. GERMANY

                         8.1.2.2. FRANCE

                         8.1.2.3. U.K.

                         8.1.2.4. ITALY

                         8.1.2.5. SPAIN

                         8.1.2.6. RUSSIA

                         8.1.2.7. TURKEY

                         8.1.2.8. BELGIUM

                         8.1.2.9. NETHERLANDS

                         8.1.2.10. SWITZERLAND

                         8.1.2.11. REST OF EUROPE

                8.1.3. ASIA-PACIFIC (APAC)

                         8.1.3.1. JAPAN

                         8.1.3.2. CHINA

                         8.1.3.3. SOUTH KOREA

                         8.1.3.4. INDIA

                         8.1.3.5. AUSTRALIA

                         8.1.3.6. SINGAPORE

                         8.1.3.7. THAILAND

                         8.1.3.8. MALAYSIA

                         8.1.3.9. INDONESIA

                         8.1.3.10. PHILIPPINES

                         8.1.3.11. REST OF APAC

                8.1.4. LATIN AMERICA

                         8.1.4.1. BRAZIL

                         8.1.4.2. REST OF LATIN AMERICA

                8.1.5. MIDDLE EAST AND AFRICA

                         8.1.5.1. SOUTH AFRICA

                         8.1.5.2. REST OF MIDDLE EAST AND AFRICA

    8.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

9. IUCD MARKET: COMPETITIVE LANDSCAPE

    9.1. GLOBAL IUCD MARKET: COMPANY SHARE ANALYSIS

    9.2. U.S. IUCD MARKET: COMPANY SHARE ANALYSIS

    9.3. EUROPE IUCD MARKET: COMPANY SHARE ANALYSIS

    9.4. APAC IUCD MARKET: COMPANY SHARE ANALYSIS

    9.5. SOUTH AMERICA IUCD MARKET: COMPANY SHARE ANALYSIS

    9.6. MIDDLE EAST AND AFRICA  IUCD MARKET: COMPANY SHARE ANALYSIS 

    9.7. MERGERS & ACQUISITIONS

    9.8. NEW PRODUCT DEVELOPMENT & APPROVALS

    9.9. EXPANSIONS

    9.10. REGULATORY CHANGES

    9.11. PARTNERSHIP AND OTHER STRATEGIC developments

10. IUCD MARKET, COMPANY PROFILES

    10.1. BAYER HEALTHCARE AG

            10.1.1. OVERVIEW

            10.1.2. SWOT ANALYSIS

            10.1.3. PRODUCT PORTFOLIO

            10.1.4. REVENUE ANALYSIS

            10.1.5. ANALYSTS VIEW

    10.2. DKT INTERNATIONAL

            10.2.1. OVERVIEW

            10.2.2. SWOT ANALYSIS

            10.2.3. PRODUCT PORTFOLIO

            10.2.4. REVENUE ANALYSIS

            10.2.5. ANALYSTS VIEW

    10.3. EGEMEN INTERNATIONAL

            10.3.1. OVERVIEW

            10.3.2. SWOT ANALYSIS

            10.3.3. PRODUCT PORTFOLIO

            10.3.4. REVENUE ANALYSIS

            10.3.5. ANALYST VIEW

    10.4. MELBEA AG.

            10.4.1. OVERVIEW

            10.4.2. SWOT ANALYSIS

            10.4.3. PRODUCT PORTFOLIO

            10.4.4. REVENUE ANALYSIS

            10.4.5. ANALYSTS VIEW

    10.5. TEVA PHARMACEUTICALS INDUSTRIES LTD

            10.5.1. OVERVIEW

            10.5.2. SWOT ANALYSIS

            10.5.3. PRODUCT PORTFOLIO

            10.5.4. REVENUE ANALYSIS

            10.5.5. ANALYSTS VIEW

    10.6. ACTAVIS PLC.

           10.6.1. OVERVIEW

           10.6.2. SWOT ANALYSIS

           10.6.3. PRODUCT PORTFOLIO

           10.6.4. REVENUE ANALYSIS

           10.6.5. ANALYSTS VIEW

    10.7. OCON MEDICAL LTD.

            10.7.1. OVERVIEW

            10.7.2. SWOT ANALYSIS

            10.7.3. PRODUCT PORTFOLIO

            10.7.4. REVENUE ANALYSIS

            10.7.5. ANALYSTS VIEW

    10.8. PREGNA INTERNATIONAL LIMITED

            10.8.1. OVERVIEW

            10.8.2. SWOT ANALYSIS

            10.8.3. PRODUCT PORTFOLIO

            10.8.4. REVENUE ANALYSIS

            10.1.5. ANALYSTS VIEW

    10.9. MEDICAL ENGINEERING CORPORATION SA

            10.9.1. OVERVIEW

            10.9.2. SWOT ANALYSIS

            10.9.3. PRODUCT PORTFOLIO

            10.9.4. REVENUE ANALYSIS

            10.9.5. ANALYSTS VIEW

    10.10. SMB CORPORATION

             10.10.1. OVERVIEW

             10.10.2. SWOT ANALYSIS

             10.10.3. PRODUCT PORTFOLIO

             10.10.4. REVENUE ANALYSIS

             10.10.5. ANALYSTS VIEW

    10.11. MERIL LIFE SCIENCES PVT. LTD.

             10.11.1. OVERVIEW

             10.11.2. SWOT ANALYSIS

             10.11.3. PRODUCT PORTFOLIO

             10.11.4. REVENUE ANALYSIS

             10.11.5. ANALYSTS VIEW

    10.12. Mona Lisa N.V.

             10.12.1. OVERVIEW

             10.12.2. SWOT ANALYSIS

             10.12.3. PRODUCT PORTFOLIO

             10.12.4. REVENUE ANALYSIS

             10.12.5. ANALYSTS VIEW

11. APPENDIX

12. ABOUT DATA BRIDGE MARKET RESEARCH

 

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Related Reports:

Global Dual Emission X-Ray Absorptiometry (DEXA) Equipment Market – Trends and Forecast to 2022

Global Dual Emission X-Ray Absorptiometry (DEXA) Equipment Market, By Product Type (Central DEXA, Peripheral DEXA), By Application (Body Composition Analysis, Fracture Diagnosis, Bone Densitometry, Fracture Risk Assessment), By End-User (Hospitals, Clinics, Mobile Health Centers, Over the Counter), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) – Trends and Forecast to 2022

Global Nerve Repair Biomaterials Market – Trends and Forecast to 2022

Global Nerve Repair Biomaterials Market, By Product Type (Nerve Repair (Nerve Conduit, Nerve Graft (Allograft, Acellularized Allograft)), Nerve Protection (Nerve Protectors, Nerve Wrap), By Injury Type (Epineural Nerve Repair, Perineural Nerve Repair, Group Fascicular Repair), By End User (Hospital, Clinics, Ambulatory Trauma Centers), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) – Trends and Forecast to 2022

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Shubham Dwivedi
Email: Sales@databridgemarketresearch.com
Phone: +1-888-387-2818
Address:Mega Center Magarpatta City
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-intra-uterine-contraceptive-devices-market/

Comments are closed.